Pro Medicus Ltd's stock surged 5.70% during intraday trading on Wednesday, following announcements of significant new contracts for its medical imaging technology.
The company's subsidiary, Visage Imaging, secured a substantial AU$23 million contract with the University of Maryland Medical System (UMMS). This five-year agreement involves the implementation of Pro Medicus's cloud-based Visage 7 enterprise imaging platform across UMMS facilities, with a target go-live date in early 2027.
Additionally, the company announced another contract specifically for its Visage 7 Viewer and Visage 7 Workflow solutions. These contract wins represent important business developments that have driven investor confidence and contributed to the stock's strong performance in the session.